chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came in to pharmacy on 10/6/22 and asked for flu shot.  He received FluAD Lot 346336 in left arm billed through his insurance.  Upon filing his flu forms later in the evening, we realized he had already received a flu shot this year from our facility, Fluzone High Dose 0.7ml Lot UJ875AB on 9/8/22, also billed through the same insurance.  The plan accepted and paid for both shots, it never gave us any rejections.  No adverse event that we know of has taken place other than receiving 2 flu vaccines one month apart.  Patient is hard of hearing, does not speak well, and not sure if he is able to read.  He has only used our pharmacy for vaccines so we are not sure of his primary care physician.
Patient was given a dose of influenza vaccine 11/19/21 after parent consented to the vaccine.  It was found out after that the patient had already received the influenza vaccine approximately 2 weeks ago (not documentation on 1st dose lot number or manufacturer). The first dose was given at another facility. Additional notes from reporter as follows " There may have been a language barrier and ensuring the use of the translator would be helpful.  Also the vaccine was given before the screening questionnaire was filled out which may have caught the error."
Fatigue; low grade fever; reddening on her face on the nasal labial area or smile line area; a very sore left arm for a day; a very sore left arm for a day and swelled up a little; This is a spontaneous report from a contactable nurse.  A 63-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EJ1685), via an unspecified route of administration on the left arm on 19Dec2020 16:15 at SINGLE DOSE for COVID-19 immunization at the hospital. It was reported that the patient was menopausal. Ongoing medical histories included gastrooesophageal reflux disease (GERD), iron deficiency (reported as iron supplementation), sinus disorder, hypersensitivity; and hair disorder, nail disorder and immune system disorder (reported as help with hair and nail and immune system). Ongoing concomitant medications included fexofenadine hydrochloride (ALLEGRA) since unknown date (reported as taking for a year) for sinus and allergies, calcium (CALCIUM) since unknown date (reported as taking for a year) for menopause, famotidine (FAMOTIDINE) since unknown date (reported as taking for a year) for GERD, cyanocobalamin (VITAMIN B12) since unknown date (reported as taking for a year) to help with hair and nail and immune system, colecalciferol (VITAMIN D 3) since unknown date (reported as taking for a year or two) for menopause and multivitamin since unknown date (taking for 5 years at least). The patient received the first dose of the Pfizer COVID 19 vaccine on 19Dec2020 at 1615PM in the left arm. She then reported of a very sore left arm for a day and it swelled up a little on that same day. She then felt some fatigue a little the next day (20Dec2020) on Sunday but it didn't prevent her from going to work. On 20Dec2020 to 21Dec2020 (Sunday to Monday), she noticed a low-grade fever for a maybe 12 hours but she couldn't find a thermometer and doesn't know her temperature. She also developed a reddening on her face on the nasal labial area or smile line area but not very pronounced on 20Dec2020 (noticed it for about 8 to 12 hours). All of her symptoms resolved by the 21Dec2020. The events does require a visit to physician office or emergency room (ER).
I have received my 1st dose of Pfizer Vaccine last 04/09. It's like 15-20mins after receiving the vaccine, I noticed ringing in my ear that lasted few to several minutes then it went away but came back again when i get home. it was like on and off ringing in my ears.
RT shoulder IM 11/29/01. Thursday received IM Pneumonia. 11/20/01 Friday--developed red line front of shoulder. 12/1/01 Hot, painful line in armpit. Saw doctor was started on antibiotic. Fine now.
NO medical adverse events were experienced. Report is being filed d/t vaccination error - vaccine was administered to patient but was not what was ordered by provider. The concerning issue was the likeness in color/labeling of the Vaxneuvance that was administered in comparison to the Influenza (Flucelvax) that was ordered. Almost identical coloring on single dose syringes. Intent with filing report is to create awareness of this to minimize it happening in the future.
I am quite petite and the vaccination was administered very high in my left deltoid. Immediately after the injection I had intense pain in that shoulder/arm. The pain did not go away over the next few days as I have experienced in the past. Now it is nearly a month later and I still have significant weakness and pain with certain arm movements. I cannot sleep on my left side without pain and burning in my left shoulder. I take 400mg ibuprofen twice a day and get some relief from that. I have made an appointment with my family physician.
NEUROPATHY HYPOXIA  6/10/2022 &  7/17/2022  -- RECURRENCE OF SAME SYMPTOMS
I guess I first, a couple days after the vaccine, I noticed a big red dry patch on my upper left arm. Then it grew up my neck and all over my arms and body. Everywhere except my back and my face. I went to my DR and she asked me when I got the vaccine, she said I had  psoriasis inflamatoria which has no treatment and she just had me wait it out. In a couple weeks it was completely gone.
Erythema multiforme rash on bilaterally palms of hands and bilaterally soles of feet. Pain and itching at all four sites. No treatment and rash still intact two days post vaccination.
Area of DTAP immunization about 8 cm diameter erythema with central induration.  No lymph streakly.
Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was given.  No treatment medication was given.
COVID-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (COVID-19) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065K21A, 014C21A, 028L20A and 039K20A) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    The patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concurrent medical conditions included Allergic reaction to bee sting (Bee allergy).   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Sep-2022, the patient received fifth dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. In March 2023, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2023, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was provided.
mom reports pt started running temp around 11AM; apap was given; temp @ 1AM was 103; pt was given APAP; mom stated took pt to MD 28JAN94 & white blood cells up-MD felt had a virus; pt seen on 5FEB94 for a cold; 31JAN94 dx w/OM-t99.6 R;
Redness, itching, soreness that is still present 30 days after 2nd dose.
After receiving the second Shingrix vaccination in 48 hours I was having daily bouts of diarrhea, stomach cramps, and upset stomach. I have chronic fatigue and less stamina. I have had to cut down my work hours because of not feeling well and change my eating habits. I am a Pescatarian/Vegetarian and I am not able to eat salads and have fruit the way I use to eat. I also have inflammation in my body showing up in my wrists and my knees.
Pt. o.k. at Family planning appt. Immunizations below given with problems. Patient called 9/10/08 c/o joints hurting, rt.elbow, lt.knee, rt. foot & neck. Advised try advil and better that pm to 9/11/08 am. Pt. states thinks had fever night of 9/08/08 some shivers but none since. Better today 9/11/08
No adverse effect; administered improperly stored dose; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 16-JUL-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), therapy type rHA, injection, lot # S003178 with expiration date on 30-JUL-2020 (the exact dose and route of administration were not reported) for prophylaxis. The vaccine underwent a temperature excursion of 6 to 14 (7.7) degrees Fahrenheit for 305 minutes. Digital Data Logger was involved in recording of the excursion. No previous temperature excursions were reported. No adverse effects were reported. The sterile diluent  used to reconstitute the vaccines was stored properly.  This is one of two reports received from the same source.; Sender's Comments:  US-009507513-1907USA011351:
This spontaneous report was received from a nurse practitioner and refers to a 12-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medications was provided. On 27-SEP-2018 (one week before the patient got a second dose only seven days after the first dose), the patient was vaccinated with first dose of GARDASIL 9 (dose, route and site of administration, lot # and expiration date were not reported) for prophylaxis. On 04-OCT-2018 (reported as one week ago) the patient was inadvertently administered a second dose of GARDASIL 9 (dose, route and site of administration, lot # and expiration date were not reported) only seven days after the first dose (Vaccination error, Inappropriate schedule of drug administration). No adverse effects were reported.
Swollen lymph node (assume) along right side of neck just above collar bone. (started approx 24hr after vaccination)  Additionally began to have fever 24hrs after shot. (101.3 degrees was max)
Swelling of arm and hand, immediate stinging pain from the injection site to not quite my elbow for approximately 20 minutes, immediate headache followed by a migraine 24 hours after the injection. Day 3 and still have some swelling in left arm and tenderness in the arm.
Pt received 1st dose at 6:10PM. Was sitting in observation area for approximately 10 minutes when patient fainted in her seat slumped over. Patient did not respond to questions. EMS called. Patient was transported to the observation tent and was placed on cot in supine position with legs elevated. Initial vital signs BP 150/91, HR 127, 99% Room air, Temp 97.3 F. Patient regained consciousness and was able to respond to questions. Repeat vital signs 5 minutes later were BP 133/83, HR 117. EMS arrived on the scene and patient was advised to go to the hospital for further evaluation. Patient was transported via EMS.
Dizziness especially in the morning and with position changes. No treatment. Has happened since Tuesday am.
Patient had the FLUZONE HD Shot on October 10th 2018 and he came to pharmacy on Jan. 4th, 2019 saying his arm where the shot was given still hurts. Patient think that the pharmacist might have given the shot at the bone. Patient was advised to rotate warm pack on and off the injection site and take pain reliever if required.
Starting 3 days after receiving the booster dose, my blood pressure went up 10 points and has remained high ever since even with taking medication and adjusting diet. I have not seen a normal BP since then (it was never high before). Since the booster dose, I have become very sensitive to light and, when I went to see the optometrist, they said I did not have cataracts. However, I was given UV blocking glasses to wear at night but that does not help. I feel a pressure surrounding my heart and its concerning. For some reason, whenever I try to take a step or get up I have a hard time mentally deciding whether I can take a step or get up or not. I am unable to climb stairs while holding objects, and I do not feel like my normal self anymore. I have been noticing abnormal sleeping habits where I am unable to sleep at normal times (staying up late) and waking up easily. I am still experiencing these symptoms.
9FEB98 noon site swelling round lump warm (x3);welts down arm;+itching;2-10 small bumps (not vesicles) @ site & hot;deltoid swollen, itching @ site;
My  skin became very sensitive to touch 4-5 days ago, then I noticed some pain in my left leg like muscle overuse, then I woke up yesterday and found a rash.  Dr.  said its Shingles  and said it is likely due to the vaccine.
I started having vaginal bleeding on April 14th. The first day, it was the same amount as a regular period. In the days following, the bleeding became very heavy, having me go through a super-sized tampon with a pad every 1 and a half to two hours along with several large blood clots each time changing. On the 15th, I called the on-call nurse for my gynocologist and she said that it might have been from the vaccine and taking birth control, since many patients of hers had called with the same problem. The bleeding continued at this rate all the way until my second dose on April 29th. I saw my primary doctor that day and she tested my hemoglobin, which came up at 10.7, which was slightly anemic. She prescribed an Iron supplement and told me to skip my "period" days and go straight to my next pack of birth control when the one I was using was finished. The next day, I experienced severe nausea, diarrhea, chills, fever-like symptoms, difficulty breathing, and extreme fatigue. I went to the Emergency Room, and they gave me about an IV and a half. They said I had extreme dehydration, and was slightly more anemic than when tested the day before.  Following that day, the bleeding was significantly lighter and then stopped for a few days on the following Thursday when I started my new pack of birth control. I had little to no blood for.a couple days, followed by bloody discharge up until Tuesday night, the 11th of May, when the bleeding started again, being about the same amount as a regular period. I am still currently bleeding at this rate.
3 MINUTES AFTER RECEIVING THE VACCINE, HE FELT FLUSH AND DIFFERENT THAN EVER BEFORE. ON SITE EMS RESPONDED AND VITALS ARE BELOW. 25MG DIPHENHYDRAMINE WAS GIVEN. HE WAS MONITORED AND RELEASED TO HOME
PATIENT DIED 10/27/08-autopsy report received-COD undetermined. No injuries or natural causes identified. Toxicology, histology, culture, electrolyte, renal and metabolic screens non-contributory. History of co-sleeping with adult. Evidence of resuscitation attempt. krk
moderna covid 19 vaccine eua fever, chills, terrible headache, body aches, nausea, can barely move my left arm taking acetaminophen and ibuprofen to manage symptoms without much resolution
After receiving the vaccine my wife drove me from the back of the building to the front of the building to wait. During the minute it took to drive around, I felt unwell. I felt a sudden heat go from both sides of my neck, up both sides of my face to the top of my head.  Within a few minutes I noticed hives on my neck and face. I did NOT have any trouble breathing. We were concerned, so we walked to the health department front door in case my symptoms worsened.  The symptoms did not changes. We went back into the care to search on line for allergic symptoms. We went inside to report the allergic reaction. Two nurses looked at me. By this time 30 minutes has passed and my symptoms were starting to resolve. They said to go to the ED if the symptoms worsended. I sat another 30 minutes for more symptom decrease. We drove to a pharmacy for benadryl. I went home and slept serveral hours. The hives did not completely resolve unti overnight. I informed my physician weeks later. She advised not to get the second shot of Moderna.  I am interested in getting the Johnson and Johnson vaccine. Please advise.
No Adverse Event; Caller is the parent of a 3 year old who received Modern Covid vaccine a few weeks ago on 09De2022 Lot#018C22A but was given the 6 year to 12 year old dose instead of the 6 month to 5 year dose.; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Caller is the parent of a 3 year old who received Modern Covid vaccine a few weeks ago on 09De2022 Lot#018C22A but was given the 6 year to 12 year old dose instead of the 6 month to 5 year dose.) and NO ADVERSE EVENT (No Adverse Event) in a 3-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018C22A) for COVID-19 prophylaxis.     Previously administered products included for Influenza: Flu vaccine. Past adverse reactions to the above products included No adverse event with Flu vaccine.    On 09-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Dec-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG PRODUCT ADMINISTERED (Caller is the parent of a 3 year old who received Modern Covid vaccine a few weeks ago on 09De2022 Lot#018C22A but was given the 6 year to 12 year old dose instead of the 6 month to 5 year dose.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (Caller is the parent of a 3 year old who received Modern Covid vaccine a few weeks ago on 09De2022 Lot#018C22A but was given the 6 year to 12 year old dose instead of the 6 month to 5 year dose.) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Caller is the parent of a 3 year old who received Modern Covid vaccine a few weeks ago on 09De2022 Lot#018C22A but was given the 6 year to 12 year old dose instead of the 6 month to 5 year dose.).    No concomitant medication information was provided. It was reported that patient received Modern Covid vaccine a few weeks ago on 09-Dec-2022 with Lot no 018C22A but was given the 6 year to 12 year old dose instead of the 6 month to 5 year dose. This dose administered was the patient's first dose of primary series. No treatment medications were provided.
LEGS AMPUTATED WITHIN ALMOST HOURS (THEY FOUGHT IT FOR 2 DAYS); This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was perfectly healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced legs amputated within almost hours (they fought it for 2 days). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of legs amputated within almost hours (they fought it for 2 days) was not reported. This report was non-serious.
Information has been received from a health professional concerning a 14 month old male who, at 12 months, in approximately March 2005, was vaccianted once with a 0.5ml subcutaneous dose of varicella virus vaccine live. There was no concomitant medication. Last week, in May 2005 the patient experienced a breakthrough case of varicella. The patient was put on Acyclovir Zovirax and the lesions crusted over and healed. The patient was reported as recovered. No product quality complaint was involved. Additional information has been requested.
itchy neck - 6 hours later (continued until present- now is red and chapped) uncontrollable nosebleeds 40 hours later and 7 days later  (2 ER visits) ENT Specialist followup - no known cause for these nosebleeds! elevated aPTT level - will see Hematologist anxiety  (can't sleep at night)  Never had this in my life! CT scan Sinuses
The patient experienced  fever and muscle pain following dose two of Shingrix; The patient experienced  fever and muscle pain following dose two of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) (batch number L949T, expiry date 16th April 2022) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (1st dose received on an unknown date, refer case US2020075004).   On 30th April 2020, the patient received the 2nd dose of Shingrix. On 30th April 2020, less than a day after receiving Shingrix, the patient experienced fever and myalgia. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever and myalgia were unknown.   It was unknown if the reporter considered the fever and myalgia to be related to Shingrix.  Additional details were reported as follows:  The age at vaccination was not reported. HCP describes the fever and muscle pain following dose two as more severe than the experiences following dose two.  Dose two experiences began the morning after dose two was administered.  The reporter consented to follow up.